Insider: Feener Edward P. CHIEF SCIENTIFIC OFFICER - KalVista Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 72,858 | 0 | 72,858 |
| Value | $903,439.20 | $0.00 | $903,439.20 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 05/20/2024 | DDS | 8,088 | Direct | COM | $11.76 | $95,151.28 | 72,858 |
| 02/20/2024 | DDS | 19,591 | Direct | COM | $14.04 | $274,991.03 | 62,457 |
| 02/20/2024 | DDS | 8,397 | Direct | COM | $14.11 | $118,521.98 | 82,048 |
| 02/20/2024 | DDS | 300 | Direct | COM | $14.72 | $4,416.00 | 62,157 |
| 02/14/2024 | DDS | 28,171 | Direct | COM | $15.01 | $422,826.99 | 71,657 |
| 01/11/2024 | DDS | 22,679 | Direct | COM | $13.03 | $295,514.17 | 39,828 |
| 01/09/2024 | DDS | 100 | Direct | COM | $13.00 | $1,300.00 | 62,507 |
| 01/08/2024 | DDS | 17,221 | Direct | COM | $13.01 | $224,000.44 | 62,607 |
| 11/20/2023 | DDS | 4,958 | Direct | COM | $8.23 | $40,800.87 | 79,828 |
| 08/18/2023 | DDS | 4,976 | Direct | COM | $10.73 | $53,386.01 | 73,289 |
| 05/18/2023 | DDS | 1,786 | Direct | COM | $10.14 | $18,117.90 | 66,771 |
| 11/18/2022 | DDS | 530 | Direct | COM | $5.44 | $2,883.20 | 62,376 |
| 08/17/2022 | DDS | 532 | Direct | COM | $14.96 | $7,959.73 | 61,132 |
| 11/01/2021 | DDS | 6,000 | Direct | COM | $18.07 | $108,423.60 | 2,234 |
| 08/02/2021 | DDS | 6,000 | Direct | COM | $20.52 | $123,133.80 | 8,234 |
| 05/03/2021 | DDS | 6,000 | Direct | COM | $24.84 | $149,050.80 | 54,234 |
| 02/23/2021 | DDS | 1,288 | Direct | COM | $35.19 | $45,324.85 | 83,946 |
| 02/23/2021 | DDS | 23,441 | Direct | COM | $33.72 | $790,533.66 | 60,505 |
| 02/23/2021 | DDS | 800 | Direct | COM | $31.73 | $25,384.24 | 54,234 |
| 02/23/2021 | DDS | 5,471 | Direct | COM | $32.97 | $180,399.66 | 55,034 |
| 11/02/2020 | DDS | 6,000 | Direct | COM | $17.14 | $102,811.80 | 72,734 |
| 10/21/2020 | DDS | 3,600 | Direct | COM | $17.65 | $63,554.04 | 84,141 |
| 10/21/2020 | DDS | 5,407 | Direct | COM | $18.75 | $101,374.22 | 78,734 |
| 10/20/2020 | DDS | 5,600 | Direct | COM | $17.26 | $96,683.44 | 90,041 |
| 10/20/2020 | DDS | 2,300 | Direct | COM | $18.00 | $41,406.90 | 87,741 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research